MPM BIOIMPACT LLC
CIK 0001687078
Annualised vol
12.099543%
Beta
0.189095
HHI
463.40211
Top-10 weight
55.291675%
VaR 95%
1.03319%
VaR 99%
2.251095%
Max drawdown
20.62389%
Matched value
86.295242%
Returns of reported holdings
Loading returns…
Position changes vs prior quarter
What the latest 13F shows bought and sold against the quarter before, by share count.
| Ticker | Change | Shares now | Shares before | Share change % | Value now ($) |
|---|---|---|---|---|---|
| CGEM | ADDED | 9,731,341 | 7,648,268 | 27.24% | 177,207,720 |
| AKTS | UNCHANGED | 4,835,872 | 4,835,872 | 0.0% | 155,860,155 |
| LQDA | REDUCED | 1,386,174 | 1,405,158 | -1.35% | 110,519,653 |
| RVMD | REDUCED | 492,483 | 506,776 | -2.82% | 92,232,216 |
| CORT | REDUCED | 771,028 | 985,700 | -21.78% | 67,040,885 |
| EWTX | REDUCED | 1,620,780 | 1,660,696 | -2.4% | 65,852,291 |
| TVTX | REDUCED | 1,122,731 | 1,133,365 | -0.94% | 63,782,348 |
| DBVT | REDUCED | 3,666,284 | 5,213,361 | -29.68% | 60,127,058 |
| TRVI | REDUCED | 3,073,577 | 3,298,430 | -6.82% | 57,322,211 |
| ALMS | REDUCED | 2,019,020 | 2,386,529 | -15.4% | 56,815,223 |
| RLAY | ADDED | 2,415,672 | 2,359,586 | 2.38% | 45,197,223 |
| DYN | ADDED | 1,922,093 | 1,408,152 | 36.5% | 42,689,686 |
| BIOA | NEW | 1,667,661 | - | - | 40,874,371 |
| URGN | REDUCED | 933,415 | 943,803 | -1.1% | 34,349,672 |
| MLTX | REDUCED | 1,606,967 | 1,811,082 | -11.27% | 31,287,647 |
| PVLA | REDUCED | 204,027 | 206,404 | -1.15% | 31,179,406 |
| TSHA | NEW | 4,500,000 | - | - | 30,645,000 |
| SNDX | REDUCED | 1,333,523 | 1,340,733 | -0.54% | 29,150,813 |
| GLUE | REDUCED | 1,161,081 | 1,176,928 | -1.35% | 28,098,160 |
| ZURA | NEW | 4,472,843 | - | - | 26,389,774 |
| NTRA | REDUCED | 92,638 | 93,074 | -0.47% | 25,146,585 |
| STOK | REDUCED | 723,314 | 767,038 | -5.7% | 23,666,834 |
| ANL | NEW | 1,936,291 | - | - | 22,267,347 |
| BLTE | ADDED | 137,208 | 88,045 | 55.84% | 21,127,974 |
| ORIC | ADDED | 1,882,162 | 1,803,945 | 4.34% | 20,383,814 |
| TARS | REDUCED | 322,007 | 329,750 | -2.35% | 20,267,121 |
| ANNX | NEW | 3,544,354 | - | - | 20,238,261 |
| DRUG | REDUCED | 202,114 | 212,175 | -4.74% | 14,188,403 |
| TRDA | NEW | 1,253,053 | - | - | 9,222,470 |
| ACRS | ADDED | 1,042,467 | 391,918 | 165.99% | 5,514,650 |
| CNTX | REDUCED | 1,299,046 | 10,679,391 | -87.84% | 719,542 |
| HOWL | REDUCED | 80,142 | 1,208,810 | -93.37% | 28,851 |
| CLYM | CLOSED OUT | 0 | 2,593,439 | -100.0% | 0 |
| ALLO | CLOSED OUT | 0 | 2,242,933 | -100.0% | 0 |
| CRVS | CLOSED OUT | 0 | 1,674,875 | -100.0% | 0 |
| EVMN | CLOSED OUT | 0 | 1,455,863 | -100.0% | 0 |
| AGIO | CLOSED OUT | 0 | 1,306,261 | -100.0% | 0 |
| ARQT | CLOSED OUT | 0 | 733,966 | -100.0% | 0 |
| XENE | CLOSED OUT | 0 | 588,706 | -100.0% | 0 |
| ZYME | CLOSED OUT | 0 | 565,249 | -100.0% | 0 |
| CYTK | CLOSED OUT | 0 | 500,000 | -100.0% | 0 |
Holdings (latest quarter)
| Ticker | Change | Issuer | Class | CUSIP | Value ($) | Weight % | Shares |
|---|---|---|---|---|---|---|---|
| CGEM | ADDED | Cullinan Therapeutics, Inc. | 230031106 | 230031106 | 177,207,720 | 10.81 | 9731341.0 |
| AKTS | UNCHANGED | Aktis Oncology, Inc. | 01021M104 | 01021M104 | 155,860,155 | 9.5 | 4835872.0 |
| LQDA | REDUCED | Liquidia Corporation | 53635D202 | 53635D202 | 110,519,653 | 6.74 | 1386174.0 |
| RVMD | REDUCED | Revolution Medicines, Inc. | 76155X100 | 76155X100 | 92,232,216 | 5.62 | 492483.0 |
| CORT | REDUCED | Corcept Therapeutics, Inc. | 218352102 | 218352102 | 67,040,885 | 4.09 | 771028.0 |
| EWTX | REDUCED | Edgewise Therapeutics Inc | 28036F105 | 28036F105 | 65,852,291 | 4.02 | 1620780.0 |
| TVTX | REDUCED | Travere Therapeutics Inc | 89422G107 | 89422G107 | 63,782,348 | 3.89 | 1122731.0 |
| DBVT | REDUCED | DBV Technologies S A | 23306J309 | 23306J309 | 60,127,058 | 3.67 | 3666284.0 |
| TRVI | REDUCED | Trevi Therapeutics Inc | 89532M101 | 89532M101 | 57,322,211 | 3.5 | 3073577.0 |
| ALMS | REDUCED | Alumis Inc | 022307102 | 022307102 | 56,815,223 | 3.46 | 2019020.0 |
| - | Uniqure NV | N90064101 | N90064101 | 56,462,881 | 3.44 | 1225855.0 | |
| - | Ultragenyx Pharmaceuticals, Inc. | 90400D108 | 90400D108 | 47,354,199 | 2.89 | 1418215.0 | |
| RLAY | ADDED | Relay Therapeutics Inc. | 75943R102 | 75943R102 | 45,197,223 | 2.76 | 2415672.0 |
| - | Abivax SA | 00370M103 | 00370M103 | 44,821,601 | 2.73 | 336347.0 | |
| DYN | ADDED | Dyne Therapeutics, Inc. | 26818M108 | 26818M108 | 42,689,686 | 2.6 | 1922093.0 |
| - | Dianthus Therapeutics Inc | 252828108 | 252828108 | 40,941,795 | 2.5 | 420002.0 | |
| BIOA | NEW | BIOAGE Labs Inc | 09077V100 | 09077V100 | 40,874,371 | 2.49 | 1667661.0 |
| URGN | REDUCED | Urogen Pharma Ltd | M96088105 | M96088105 | 34,349,672 | 2.09 | 933415.0 |
| MLTX | REDUCED | MoonLake Immunotherapeutics | 61559X104 | 61559X104 | 31,287,647 | 1.91 | 1606967.0 |
| PVLA | REDUCED | Palvella Therapeutics Inc | 697947109 | 697947109 | 31,179,406 | 1.9 | 204027.0 |
| TSHA | NEW | Taysha Gene Therapies, Inc. | 877619106 | 877619106 | 30,645,000 | 1.87 | 4500000.0 |
| SNDX | REDUCED | Syndax Pharmaceuticals Inc | 87164F105 | 87164F105 | 29,150,813 | 1.78 | 1333523.0 |
| GLUE | REDUCED | Monte Rosa Therapeutics Inc | 61225M102 | 61225M102 | 28,098,160 | 1.71 | 1161081.0 |
| ZURA | NEW | Zura Bio Ltd. | G9TY5A101 | G9TY5A101 | 26,389,774 | 1.61 | 4472843.0 |
| NTRA | REDUCED | Natera Inc | 632307104 | 632307104 | 25,146,585 | 1.53 | 92638.0 |
| STOK | REDUCED | Stoke Therapeutics Inc | 86150R107 | 86150R107 | 23,666,834 | 1.44 | 723314.0 |
| ANL | NEW | Adlai Nortye Ltd | 00704R109 | 00704R109 | 22,267,347 | 1.36 | 1936291.0 |
| BLTE | ADDED | Belite Bio Inc | 07782B104 | 07782B104 | 21,127,974 | 1.29 | 137208.0 |
| - | Forte Biosciences, Inc. | 34962G208 | 34962G208 | 20,983,270 | 1.28 | 987448.0 | |
| ORIC | ADDED | Oric Pharmaceuticals Inc | 68622P109 | 68622P109 | 20,383,814 | 1.24 | 1882162.0 |
| TARS | REDUCED | Tarsus Pharmaceuticals Inc | 87650L103 | 87650L103 | 20,267,121 | 1.24 | 322007.0 |
| ANNX | NEW | Annexon Inc | 03589W102 | 03589W102 | 20,238,261 | 1.23 | 3544354.0 |
| DRUG | REDUCED | Bright Minds Biosciences Inc | 10919W405 | 10919W405 | 14,188,403 | 0.87 | 202114.0 |
| TRDA | NEW | Entrada Therapeutics, Inc. | 29384C108 | 29384C108 | 9,222,470 | 0.56 | 1253053.0 |
| ACRS | ADDED | Aclaris Therapeutics Inc | 00461U105 | 00461U105 | 5,514,650 | 0.34 | 1042467.0 |
| CNTX | REDUCED | Context Therapeutics Inc | 21077P108 | 21077P108 | 719,542 | 0.04 | 1299046.0 |
| HOWL | REDUCED | Werewolf Therapeutics, Inc. | 95075A107 | 95075A107 | 28,851 | 0.0 | 80142.0 |
Quarterly portfolios
| Period | Filed | Value ($) | Positions | Vol % | Beta | Max DD % |
|---|---|---|---|---|---|---|
| 2026-06-30 | 2026-08-14 | 1,639,957,110 | 37 | 12.099543 | 0.189095 | 20.62389 |
| 2026-03-31 | 2026-05-15 | 1,294,902,368 | 41 | 11.693931 | 0.163141 | 17.11746 |
| 2025-12-31 | 2026-02-17 | 873,953,483 | 38 | 12.461735 | 0.169766 | 24.048297 |
| 2025-09-30 | 2025-11-14 | 610,879,430 | 40 | 12.668722 | 0.196104 | 22.996599 |
| 2025-03-31 | 2025-05-15 | 581,677,555 | 43 | 12.858605 | 0.215973 | 25.238407 |
| 2024-12-31 | 2025-02-14 | 704,362,373 | 47 | 13.299062 | 0.245919 | 29.202799 |